방사성의약품(Radiopharmaceuticals) 시장은 2024-2029년간 70억 2,050만 달러 확대되고, 예측기간 동안 연평균 12.3% 성장할 것으로 예상됩니다. 세계의 방사성의약품(Radiopharmaceuticals) 시장에 대해 조사 분석했으며, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더에 대한 벤더 분석 등의 정보를 전해드립니다.
현재의 시장 시나리오, 최신 동향 및 성장요인, 시장 환경 전반에 대한 최신 분석을 제공합니다. 시장은 신경질환의 유병률 증가, 암 환자 증가와 종양학 시장에 대한 투자 증가, 방사성의약품의 부작용 최소화 등이 시장을 견인하고 있습니다.
| 시장 범위 |
| 기준 연도 |
2025년 |
| 종료 연도 |
2029년 |
| 예측 기간 |
2025-2029년 |
| 성장 모멘텀 |
가속 |
| 전년 대비(2025년) |
10.7% |
| CAGR |
12.3% |
| 증분 금액 |
70억 2,050만 달러 |
이 조사는 업계 주요 참가자의 의견을 포함하여 1차 및 2차 정보를 객관적으로 결합하여 수행되었습니다. 보고서에는 주요 기업 분석, 종합적인 시장 규모 데이터, 지역 분석에 따른 부문, 공급업체 현황이 포함되어 있습니다. 보고서에는 과거 데이터와 예측 데이터가 있습니다.
이 보고서는 사이클로트론 기반 방사성의약품의 생산이 향후 몇 년간 방사성의약품 시장의 성장을 가속하는 주요 이유 중 하나로 꼽고 있습니다. 또한, 새로운 방사성의약품의 발견과 개발, 신흥 경제국의 의료 인프라 개선은 시장의 큰 수요를 창출할 것으로 예상됩니다.
목차
제1장 주요 요약
제2장 Technavio 분석
- 가격, 수명주기, 고객 구입 바스켓, 채택 비율, 구입 기준 분석
- 인풋의 중요성과 차별화 요인
- 혼란 요인
- 성장 촉진요인과 과제의 영향
제3장 시장 구도
제4장 시장 규모
- 시장의 정의
- 시장 부문 분석
- 시장 규모(2024년)
- 시장 전망(2024-2029년)
제5장 시장 규모 실적
- 세계의 방사성 의약품 시장(2019-2023년)
- 공급원별 부문 분석(2019-2023년)
- 최종사용자별 부문 분석(2019-2023년)
- 용도별 부문 분석(2019-2023년)
- 지역별 부문 분석(2019-2023년)
- 국가별 부문 분석(2019-2023년)
제6장 정성 분석
제7장 Five Forces 분석
- Five Forces 요약
- 바이어의 교섭력
- 공급 기업의 교섭력
- 신규 진출업체의 위협
- 대체품의 위협
- 경쟁 위협
- 시장 현황
제8장 시장 세분화 : 공급원별
- 시장 부문
- 비교 : 공급원별
- 사이클로트론 : 시장 규모와 예측(2024-2029년)
- 원자로 : 시장 규모와 예측(2024-2029년)
- 시장 기회 : 공급원별
제9장 시장 세분화 : 최종사용자별
- 시장 부문
- 비교 : 최종사용자별
- 진단 : 시장 규모와 예측(2024-2029년)
- 치료 : 시장 규모와 예측(2024-2029년)
- 시장 기회 : 최종사용자별
제10장 시장 세분화 : 용도별
- 시장 부문
- 비교 : 용도별
- 종양학 : 시장 규모와 예측(2024-2029년)
- 심장병학 : 시장 규모와 예측(2024-2029년)
- 신경학 : 시장 규모와 예측(2024-2029년)
- 시장 기회 : 용도별
제11장 고객 상황
제12장 지역별 상황
- 지역별 세분화
- 비교 : 지역별
- 북미 : 시장 규모와 예측(2024-2029년)
- 유럽 : 시장 규모와 예측(2024-2029년)
- 아시아 : 시장 규모와 예측(2024-2029년)
- 기타 : 시장 규모와 예측(2024-2029년)
- 미국 : 시장 규모와 예측(2024-2029년)
- 독일 : 시장 규모와 예측(2024-2029년)
- 영국 : 시장 규모와 예측(2024-2029년)
- 캐나다 : 시장 규모와 예측(2024-2029년)
- 중국 : 시장 규모와 예측(2024-2029년)
- 일본 : 시장 규모와 예측(2024-2029년)
- 프랑스 : 시장 규모와 예측(2024-2029년)
- 브라질 : 시장 규모와 예측(2024-2029년)
- 인도 : 시장 규모와 예측(2024-2029년)
- 아랍에미리트(UAE) : 시장 규모와 예측(2024-2029년)
- 지역 상황에 의한 시장 기회
제13장 성장 촉진요인, 과제, 기회, 성장 억제요인
- 시장 성장 촉진요인
- 시장이 해결해야 할 과제
- 성장 촉진요인과 과제의 영향
- 시장 기회와 성장 억제요인
제14장 경쟁 구도
제15장 경쟁 분석
- 기업 개요
- 기업 순위 지수
- 기업의 시장 포지셔닝
- Bayer AG
- Bracco Spa
- Cardinal Health Inc.
- Curium Pharma
- Eckert and Ziegler AG
- GE Healthcare Technologies Inc.
- IBA Radiopharma Solutions
- Jubilant Draximage Radiopharmacies Inc.
- Lantheus
- NorthStar Medical Radioisotopes LLC
- Novartis AG
- NTP Radioisotopes SOC Ltd.
- PharmaLogic Holdings Corp.
- Siemens AG
- Sotera Health Co.
제16장 부록
LSH
The radiopharmaceuticals market is forecasted to grow by USD 7020.5 million during 2024-2029, accelerating at a CAGR of 12.3% during the forecast period. The report on the radiopharmaceuticals market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising incidence of neurological disorders, growing cancer cases and rising investment in oncology market, and minimal side effects of radiopharmaceuticals.
| Market Scope |
|---|
| Base Year | 2025 |
| End Year | 2029 |
| Series Year | 2025-2029 |
| Growth Momentum | Accelerate |
| YOY 2025 | 10.7% |
| CAGR | 12.3% |
| Incremental Value | $7020.5 mn |
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
Technavio's radiopharmaceuticals market is segmented as below:
By Source
- Cyclotrons
- Nuclear reactors
By End-user
By Application
- Oncology
- Cardiology
- Neurology
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the production of cyclotron-based radiopharmaceuticals as one of the prime reasons driving the radiopharmaceuticals market growth during the next few years. Also, discovery and development of new radiopharmaceuticals and improvement in healthcare infrastructure in emerging economies will lead to sizable demand in the market.
The report on the radiopharmaceuticals market covers the following areas:
- Radiopharmaceuticals Market sizing
- Radiopharmaceuticals Market forecast
- Radiopharmaceuticals Market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading radiopharmaceuticals market vendors that include Bayer AG, Bracco Spa, Cardinal Health Inc., Curium Pharma, Eckert and Ziegler AG, GE Healthcare Technologies Inc., IBA Radiopharma Solutions, Jubilant Draximage Radiopharmacies Inc., Lantheus, Mallinckrodt PLC, NorthStar Medical Radioisotopes LLC, Novartis AG, NTP Radioisotopes SOC Ltd., PharmaLogic Holdings Corp., Positron Corp., Radiomedix Inc., Siemens AG, Sinotau Pharmaceuticals, Sotera Health Co., and Telix Pharmaceuticals Ltd.. Also, the radiopharmaceuticals market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market By Geographical Landscape
- Executive Summary - Chart on Market Segmentation by Source
- Executive Summary - Chart on Market Segmentation by End-user
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- Overview on criticality of inputs and factors of differentiation
- 2.3 Factors of disruption
- Overview on factors of disruption
- 2.4 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
3 Market Landscape
- 3.1 Market ecosystem
- Parent Market
- Data Table on - Parent Market
- 3.2 Market characteristics
- Market characteristics analysis
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- Offerings of companies included in the market definition
- 4.2 Market segment analysis
- 4.3 Market size 2024
- 4.4 Market outlook: Forecast for 2024-2029
- Chart on Global - Market size and forecast 2024-2029 ($ million)
- Data Table on Global - Market size and forecast 2024-2029 ($ million)
- Chart on Global Market: Year-over-year growth 2024-2029 (%)
- Data Table on Global Market: Year-over-year growth 2024-2029 (%)
5 Historic Market Size
- 5.1 Global Radiopharmaceuticals Market 2019 - 2023
- Historic Market Size - Data Table on Global Radiopharmaceuticals Market 2019 - 2023 ($ million)
- 5.2 Source segment analysis 2019 - 2023
- Historic Market Size - Source Segment 2019 - 2023 ($ million)
- 5.3 End-user segment analysis 2019 - 2023
- Historic Market Size - End-user Segment 2019 - 2023 ($ million)
- 5.4 Application segment analysis 2019 - 2023
- Historic Market Size - Application Segment 2019 - 2023 ($ million)
- 5.5 Geography segment analysis 2019 - 2023
- Historic Market Size - Geography Segment 2019 - 2023 ($ million)
- 5.6 Country segment analysis 2019 - 2023
- Historic Market Size - Country Segment 2019 - 2023 ($ million)
6 Qualitative Analysis
- 6.1 AI Impact on Global Radiopharmaceuticals Market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2024 and 2029
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2024 and 2029
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2024 and 2029
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2024 and 2029
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2024 and 2029
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2024 and 2029
- 7.7 Market condition
- Chart on Market condition - Five forces 2024 and 2029
8 Market Segmentation by Source
- 8.1 Market segments
- Chart on Source - Market share 2024-2029 (%)
- Data Table on Source - Market share 2024-2029 (%)
- 8.2 Comparison by Source
- Chart on Comparison by Source
- Data Table on Comparison by Source
- 8.3 Cyclotrons - Market size and forecast 2024-2029
- Chart on Cyclotrons - Market size and forecast 2024-2029 ($ million)
- Data Table on Cyclotrons - Market size and forecast 2024-2029 ($ million)
- Chart on Cyclotrons - Year-over-year growth 2024-2029 (%)
- Data Table on Cyclotrons - Year-over-year growth 2024-2029 (%)
- 8.4 Nuclear reactors - Market size and forecast 2024-2029
- Chart on Nuclear reactors - Market size and forecast 2024-2029 ($ million)
- Data Table on Nuclear reactors - Market size and forecast 2024-2029 ($ million)
- Chart on Nuclear reactors - Year-over-year growth 2024-2029 (%)
- Data Table on Nuclear reactors - Year-over-year growth 2024-2029 (%)
- 8.5 Market opportunity by Source
- Market opportunity by Source ($ million)
- Data Table on Market opportunity by Source ($ million)
9 Market Segmentation by End-user
- 9.1 Market segments
- Chart on End-user - Market share 2024-2029 (%)
- Data Table on End-user - Market share 2024-2029 (%)
- 9.2 Comparison by End-user
- Chart on Comparison by End-user
- Data Table on Comparison by End-user
- 9.3 Diagnostics - Market size and forecast 2024-2029
- Chart on Diagnostics - Market size and forecast 2024-2029 ($ million)
- Data Table on Diagnostics - Market size and forecast 2024-2029 ($ million)
- Chart on Diagnostics - Year-over-year growth 2024-2029 (%)
- Data Table on Diagnostics - Year-over-year growth 2024-2029 (%)
- 9.4 Therapeutics - Market size and forecast 2024-2029
- Chart on Therapeutics - Market size and forecast 2024-2029 ($ million)
- Data Table on Therapeutics - Market size and forecast 2024-2029 ($ million)
- Chart on Therapeutics - Year-over-year growth 2024-2029 (%)
- Data Table on Therapeutics - Year-over-year growth 2024-2029 (%)
- 9.5 Market opportunity by End-user
- Market opportunity by End-user ($ million)
- Data Table on Market opportunity by End-user ($ million)
10 Market Segmentation by Application
- 10.1 Market segments
- Chart on Application - Market share 2024-2029 (%)
- Data Table on Application - Market share 2024-2029 (%)
- 10.2 Comparison by Application
- Chart on Comparison by Application
- Data Table on Comparison by Application
- 10.3 Oncology - Market size and forecast 2024-2029
- Chart on Oncology - Market size and forecast 2024-2029 ($ million)
- Data Table on Oncology - Market size and forecast 2024-2029 ($ million)
- Chart on Oncology - Year-over-year growth 2024-2029 (%)
- Data Table on Oncology - Year-over-year growth 2024-2029 (%)
- 10.4 Cardiology - Market size and forecast 2024-2029
- Chart on Cardiology - Market size and forecast 2024-2029 ($ million)
- Data Table on Cardiology - Market size and forecast 2024-2029 ($ million)
- Chart on Cardiology - Year-over-year growth 2024-2029 (%)
- Data Table on Cardiology - Year-over-year growth 2024-2029 (%)
- 10.5 Neurology - Market size and forecast 2024-2029
- Chart on Neurology - Market size and forecast 2024-2029 ($ million)
- Data Table on Neurology - Market size and forecast 2024-2029 ($ million)
- Chart on Neurology - Year-over-year growth 2024-2029 (%)
- Data Table on Neurology - Year-over-year growth 2024-2029 (%)
- 10.6 Market opportunity by Application
- Market opportunity by Application ($ million)
- Data Table on Market opportunity by Application ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- Chart on Market share By Geographical Landscape 2024-2029 (%)
- Data Table on Market share By Geographical Landscape 2024-2029 (%)
- 12.2 Geographic comparison
- Chart on Geographic comparison
- Data Table on Geographic comparison
- 12.3 North America - Market size and forecast 2024-2029
- Chart on North America - Market size and forecast 2024-2029 ($ million)
- Data Table on North America - Market size and forecast 2024-2029 ($ million)
- Chart on North America - Year-over-year growth 2024-2029 (%)
- Data Table on North America - Year-over-year growth 2024-2029 (%)
- 12.4 Europe - Market size and forecast 2024-2029
- Chart on Europe - Market size and forecast 2024-2029 ($ million)
- Data Table on Europe - Market size and forecast 2024-2029 ($ million)
- Chart on Europe - Year-over-year growth 2024-2029 (%)
- Data Table on Europe - Year-over-year growth 2024-2029 (%)
- 12.5 Asia - Market size and forecast 2024-2029
- Chart on Asia - Market size and forecast 2024-2029 ($ million)
- Data Table on Asia - Market size and forecast 2024-2029 ($ million)
- Chart on Asia - Year-over-year growth 2024-2029 (%)
- Data Table on Asia - Year-over-year growth 2024-2029 (%)
- 12.6 Rest of World (ROW) - Market size and forecast 2024-2029
- Chart on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Data Table on Rest of World (ROW) - Market size and forecast 2024-2029 ($ million)
- Chart on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- Data Table on Rest of World (ROW) - Year-over-year growth 2024-2029 (%)
- 12.7 US - Market size and forecast 2024-2029
- Chart on US - Market size and forecast 2024-2029 ($ million)
- Data Table on US - Market size and forecast 2024-2029 ($ million)
- Chart on US - Year-over-year growth 2024-2029 (%)
- Data Table on US - Year-over-year growth 2024-2029 (%)
- 12.8 Germany - Market size and forecast 2024-2029
- Chart on Germany - Market size and forecast 2024-2029 ($ million)
- Data Table on Germany - Market size and forecast 2024-2029 ($ million)
- Chart on Germany - Year-over-year growth 2024-2029 (%)
- Data Table on Germany - Year-over-year growth 2024-2029 (%)
- 12.9 UK - Market size and forecast 2024-2029
- Chart on UK - Market size and forecast 2024-2029 ($ million)
- Data Table on UK - Market size and forecast 2024-2029 ($ million)
- Chart on UK - Year-over-year growth 2024-2029 (%)
- Data Table on UK - Year-over-year growth 2024-2029 (%)
- 12.10 Canada - Market size and forecast 2024-2029
- Chart on Canada - Market size and forecast 2024-2029 ($ million)
- Data Table on Canada - Market size and forecast 2024-2029 ($ million)
- Chart on Canada - Year-over-year growth 2024-2029 (%)
- Data Table on Canada - Year-over-year growth 2024-2029 (%)
- 12.11 China - Market size and forecast 2024-2029
- Chart on China - Market size and forecast 2024-2029 ($ million)
- Data Table on China - Market size and forecast 2024-2029 ($ million)
- Chart on China - Year-over-year growth 2024-2029 (%)
- Data Table on China - Year-over-year growth 2024-2029 (%)
- 12.12 Japan - Market size and forecast 2024-2029
- Chart on Japan - Market size and forecast 2024-2029 ($ million)
- Data Table on Japan - Market size and forecast 2024-2029 ($ million)
- Chart on Japan - Year-over-year growth 2024-2029 (%)
- Data Table on Japan - Year-over-year growth 2024-2029 (%)
- 12.13 France - Market size and forecast 2024-2029
- Chart on France - Market size and forecast 2024-2029 ($ million)
- Data Table on France - Market size and forecast 2024-2029 ($ million)
- Chart on France - Year-over-year growth 2024-2029 (%)
- Data Table on France - Year-over-year growth 2024-2029 (%)
- 12.14 Brazil - Market size and forecast 2024-2029
- Chart on Brazil - Market size and forecast 2024-2029 ($ million)
- Data Table on Brazil - Market size and forecast 2024-2029 ($ million)
- Chart on Brazil - Year-over-year growth 2024-2029 (%)
- Data Table on Brazil - Year-over-year growth 2024-2029 (%)
- 12.15 India - Market size and forecast 2024-2029
- Chart on India - Market size and forecast 2024-2029 ($ million)
- Data Table on India - Market size and forecast 2024-2029 ($ million)
- Chart on India - Year-over-year growth 2024-2029 (%)
- Data Table on India - Year-over-year growth 2024-2029 (%)
- 12.16 UAE - Market size and forecast 2024-2029
- Chart on UAE - Market size and forecast 2024-2029 ($ million)
- Data Table on UAE - Market size and forecast 2024-2029 ($ million)
- Chart on UAE - Year-over-year growth 2024-2029 (%)
- Data Table on UAE - Year-over-year growth 2024-2029 (%)
- 12.17 Market opportunity By Geographical Landscape
- Market opportunity By Geographical Landscape ($ million)
- Data Tables on Market opportunity By Geographical Landscape ($ million)
13 Drivers, Challenges, and Opportunity/Restraints
- 13.1 Market drivers
- 13.2 Market challenges
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2024 and 2029
- 13.4 Market opportunities/restraints
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- 15.2 Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 Bayer AG
- Bayer AG - Overview
- Bayer AG - Business segments
- Bayer AG - Key news
- Bayer AG - Key offerings
- Bayer AG - Segment focus
- SWOT
- 15.5 Bracco Spa
- Bracco Spa - Overview
- Bracco Spa - Product / Service
- Bracco Spa - Key offerings
- SWOT
- 15.6 Cardinal Health Inc.
- Cardinal Health Inc. - Overview
- Cardinal Health Inc. - Business segments
- Cardinal Health Inc. - Key news
- Cardinal Health Inc. - Key offerings
- Cardinal Health Inc. - Segment focus
- SWOT
- 15.7 Curium Pharma
- Curium Pharma - Overview
- Curium Pharma - Product / Service
- Curium Pharma - Key offerings
- SWOT
- 15.8 Eckert and Ziegler AG
- Eckert and Ziegler AG - Overview
- Eckert and Ziegler AG - Business segments
- Eckert and Ziegler AG - Key news
- Eckert and Ziegler AG - Key offerings
- Eckert and Ziegler AG - Segment focus
- SWOT
- 15.9 GE Healthcare Technologies Inc.
- GE Healthcare Technologies Inc. - Overview
- GE Healthcare Technologies Inc. - Business segments
- GE Healthcare Technologies Inc. - Key news
- GE Healthcare Technologies Inc. - Key offerings
- GE Healthcare Technologies Inc. - Segment focus
- SWOT
- 15.10 IBA Radiopharma Solutions
- IBA Radiopharma Solutions - Overview
- IBA Radiopharma Solutions - Business segments
- IBA Radiopharma Solutions - Key news
- IBA Radiopharma Solutions - Key offerings
- IBA Radiopharma Solutions - Segment focus
- SWOT
- 15.11 Jubilant Draximage Radiopharmacies Inc.
- Jubilant Draximage Radiopharmacies Inc. - Overview
- Jubilant Draximage Radiopharmacies Inc. - Product / Service
- Jubilant Draximage Radiopharmacies Inc. - Key offerings
- SWOT
- 15.12 Lantheus
- Lantheus - Overview
- Lantheus - Business segments
- Lantheus - Key offerings
- Lantheus - Segment focus
- SWOT
- 15.13 NorthStar Medical Radioisotopes LLC
- NorthStar Medical Radioisotopes LLC - Overview
- NorthStar Medical Radioisotopes LLC - Product / Service
- NorthStar Medical Radioisotopes LLC - Key offerings
- SWOT
- 15.14 Novartis AG
- Novartis AG - Overview
- Novartis AG - Business segments
- Novartis AG - Key news
- Novartis AG - Key offerings
- Novartis AG - Segment focus
- SWOT
- 15.15 NTP Radioisotopes SOC Ltd.
- NTP Radioisotopes SOC Ltd. - Overview
- NTP Radioisotopes SOC Ltd. - Product / Service
- NTP Radioisotopes SOC Ltd. - Key offerings
- SWOT
- 15.16 PharmaLogic Holdings Corp.
- PharmaLogic Holdings Corp. - Overview
- PharmaLogic Holdings Corp. - Product / Service
- PharmaLogic Holdings Corp. - Key offerings
- SWOT
- 15.17 Siemens AG
- Siemens AG - Overview
- Siemens AG - Business segments
- Siemens AG - Key news
- Siemens AG - Key offerings
- Siemens AG - Segment focus
- SWOT
- 15.18 Sotera Health Co.
- Sotera Health Co. - Overview
- Sotera Health Co. - Business segments
- Sotera Health Co. - Key news
- Sotera Health Co. - Key offerings
- Sotera Health Co. - Segment focus
- SWOT
16 Appendix
- 16.1 Scope of the report
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- 16.5 Data procurement
- 16.6 Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
